Nurx, a leading telehealth platform specializing in women’s health, is excited to announce an integration agreement with Gifthealth, Eli Lilly and Company’s LillyDirect pharmacy provider, for Zepbound (tirzepatide) single-dose vials to simplify prescription access. The arrangement will streamline access to the vials for clinically-eligible Nurx patients with an on-label prescription, ensuring they have a more seamless way to receive chronic weight management treatment.
Obesity and overweight affect more than 2 out of 3 women over the age of 20 in the United States and is a risk that increases with age. What’s more, 11.5% of women have severe obesity, a higher rate than in men. Overweight and obesity have profound health implications, increasing the risks of cardiovascular disease, type-2 diabetes, certain cancers, and complications during pregnancy. This is why addressing overweight and obesity is crucial for improving women’s health overall. However, losing weight and keeping it off can be challenging: studies show that only 1 in 10 adults with overweight and obesity achieve weight loss of 5% or more each year.
Health Technology Insights: Impilo Joins the Elation Partner Hub to Enhance At-Home Healthcare Delivery
Recognizing these challenges, Nurx is committed to providing women with effective, evidence-based weight management solutions. This integration with Gifthealth will streamline access to Zepbound, an FDA-approved medication for obesity and chronic weight management, for clinically-eligible patients with an on-label prescription from a Nurx-affiliated provider. This integration arrangement also underscores Nurx’s dedication to empowering women with the tools and support necessary to achieve their health goals.
As demand for obesity and chronic weight management medications like Zepbound continues to rise, Nurx is committed to providing comprehensive telehealth care for women navigating weight management. By integrating Gifthealth’s pharmacy fulfillment capabilities, Nurx patients will benefit from streamlined access to Zepbound vials, and can take advantage of Gifthealth’s transparent pricing and nationwide delivery — key factors in making obesity care more accessible.
“At Nurx, we believe that every woman deserves access to the healthcare solutions that best fit her needs — including safe and effective weight management medications,” said Rajani Rao, Chief Business Officer at Nurx. “This integration agreement with Gifthealth allows us to streamline barriers to access, ensuring women can get the medication they need, and pair it with Nurx’s comprehensive approach to weight management, which provides ongoing access to physicians and support in making lifestyle changes.”
Health Technology Insights: Health-E Commerce Enhances FSA, HSA Prescription Weight Management
Gifthealth has been at the forefront of prescription innovation. This new integration agreement with Nurx will help streamline the prescription fulfillment process for weight management treatments, reinforcing both companies’ missions to provide affordable, high-quality care. “We are excited to work with providers such as Nurx to streamline access to authentic Zepbound vials for women nationwide,” said Robert Hoppe, EVP of Life Sciences at Gifthealth. “Our goal is to remove cost and logistical barriers to essential medications, and through these integrations, we can help more patients get the care they need.”
Health Technology Insights: DocNow Launches Telehealth Platform for Post-Acute Providers
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – PR Newswire
